|
2025 Conference Publication The aetiology and epidemiology of nontuberculous mycobacteria (NTM) in Australians with cystic fibrosisDuplancic, C., Alene, K., Ballard, E., Thomson, R., Wainwright, C., Rogers, G., Clements, A., Floto, A., Bell, S. and O. NTM in CF Investigators (2025). The aetiology and epidemiology of nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis. 2025 North American Cystic Fibrosis Conference, Seattle, WA United States, 22-25 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(25)01654-6 |
|
2025 Conference Publication The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studiesEvans, I., Duplancic, C., Kidd, T., Ballard, E., Thomson, R., Wainwright, C., Bell, S. and O. NTM in CF Investigators (2025). The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies. 2025 North American Cystic Fibrosis Conference, Seattle, WA United States, 22-25 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(25)01642-x |
|
2025 Conference Publication Mycobacteria acquisition from potable water across the drinking water system in AustraliaRamsay, K., Smith, K., Duplancic, C., Taylor, S., Rogers, G., Wainwright, C., Thomson, R. and Bell, S. (2025). Mycobacteria acquisition from potable water across the drinking water system in Australia. 2025 North American Cystic Fibrosis Conference, Seattle, WA United States, 22-25 October 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(25)01643-1 |
|
2025 Journal Article Finding the optimal regimen for <i>Mycobacteroides abscessus</i> treatment (FOR<i>Ma</i>T) in people with <i>Mycobacteroides abscessus</i> pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trialJong, Tiffany, Baird, Timothy, Barr, Helen Louise, Bell, Scott, Bigirumurame, Theophile, Brady, Kara, Burke, Andrew, Byrnes, Joshua, Caudri, Daan, Clark, Julia E, Coin, Lachlan J M, Goh, Felicia, Grimwood, Keith, Hicks, Daniel, Jayawardana, Kaushala, Joshi, Sri, Lee, Katherine, Qvist, Tavs, Reid, David, Rice, Megan, Roberts, Jason A, Rogers, Geraint, Shackleton, Claire, Sly, Peter D, Smyth, Alan R, Stevens, Luke, Stockwell, Rebecca, Tarique, Abdullah, Taylor, Steven ... Wainwright, Claire (2025). Finding the optimal regimen for Mycobacteroides abscessus treatment (FORMaT) in people with Mycobacteroides abscessus pulmonary disease: a multicentre, randomised, multi-arm, adaptive platform trial. BMJ Open, 15 (9) e096188, e096188. doi: 10.1136/bmjopen-2024-096188 |
|
2025 Journal Article Germicidal UV Light and Incidence of Acute Respiratory Infection in Long-Term Care for Older Adults : A Randomized Clinical TrialShoubridge, Andrew P., Brass, Amanda, Crotty, Maria, Morawska, Lidia, Bell, Scott C., Flynn, Erin, Miller, Caroline, Wang, Yiming, Holden, Carol A., Corlis, Megan, Larby, Nicolas, Worley, Paul, Elms, Levi, Manning, Sarah K., Qiao, Ming, Inacio, Maria C., Wesselingh, Steve L., Papanicolas, Lito E., Woodman, Richard J., Taylor, Steven L. and Rogers, Geraint B. (2025). Germicidal UV Light and Incidence of Acute Respiratory Infection in Long-Term Care for Older Adults : A Randomized Clinical Trial. JAMA Internal Medicine, 185 (9), 1128-1135. doi: 10.1001/jamainternmed.2025.3388 |
|
2025 Journal Article The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studiesEvans, Ieuan ES, Duplancic, Christine M, Kidd, Timothy A, Ballard, Emma L, Thomson, Rachel M, Wainwright, Claire E and Bell, Scott C (2025). The changing face of cystic fibrosis research: challenges of multi-centre microbiology cohort studies. Journal of Cystic Fibrosis, 24 (5), 903-908. doi: 10.1016/j.jcf.2025.07.002 |
|
2025 Journal Article Viable viruses in airborne particles detected during cough by participants with acute respiratory viral infectionsTay, G.T.P., Niazi, S., He, C., Morawska, L., Bell, S.C., Spann, K. and Ristovski, Z. (2025). Viable viruses in airborne particles detected during cough by participants with acute respiratory viral infections. Journal of Hospital Infection, 164, 18-26. doi: 10.1016/j.jhin.2025.07.005 |
|
2025 Conference Publication Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.118 |
|
2025 Conference Publication Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial. 48th European Cystic Fibrosis Conference, Milan, Italy, 4-7 June 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jcf.2025.03.119 |
|
2025 Conference Publication Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) TrialThomson, R., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A. J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C. E. (2025). Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial. 52nd Critical Care Congress of the Society of Critical Care Medicine (SCCM), San Francisco, CA United States, 21-24 January 2023. New York, NY United States: American Thoracic Society. |
|
2025 Conference Publication Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) TrialThomson, R., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A.J., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2025). Adverse Events Related to Study Drugs in Finding the Optimal Regimen for Mycobacteroides Abscessus Treatment (Format) Trial. ATS International Conference, San Francisco, CA, United States, 16-21 May 2025. New York, NY United States: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.abstracts.a7278 |
|
2025 Journal Article Brensocatib in Bronchiectasis - A New Sheriff in Town?Bell, Scott C. and Grimwood, Keith (2025). Brensocatib in Bronchiectasis - A New Sheriff in Town?. New England Journal of Medicine, 392 (16), 1647-1648. doi: 10.1056/NEJMe2502618 |
|
2025 Journal Article Infection by clonally related Mycobacterium abscessus isolates: the role of drinking waterThomson, Rachel M., Wheeler, Nicole, Stockwell, Rebecca E., Bryant, Josephine, Taylor, Steven L, Leong, Lex E. X., Le, Trieu, Rogers, Geraint B, Carter, Robyn, Sherrard, Laura J, Powell, Harry, Simpson, Graham, Patterson-Fahy, Kirby, Wainwright, Claire E., Floto, R. Andres, Parkhill, Julian and Bell, Scott C. (2025). Infection by clonally related Mycobacterium abscessus isolates: the role of drinking water. American Journal of Respiratory and Critical Care Medicine, 211 (5), 842-853. doi: 10.1164/rccm.202409-1824oc |
|
2025 Journal Article Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosisTay, George T. P., Smith, Kim, He, Congrong, Ballard, Emma L., Wood, Michelle E., Stockwell, Rebecca E., Morawska, Lidia, Wainwright, Claire E. and Bell, Scott C. (2025). Tolerability and effectiveness of face-masks in reducing cough aerosols for children with cystic fibrosis. Journal of Cystic Fibrosis, 24 (2), 368-373. doi: 10.1016/j.jcf.2025.01.008 |
|
2025 Journal Article Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsMayer-Hamblett, Nicole, Kerper, Natanya R, Clancy, John P, Davies, Jane C, Taylor-Cousar, Jennifer L, Donaldson, Scott H, Bell, Scott C, Jain, Raksha, Simmonds, Nicholas J, Mall, Marcus A, Goss, Christopher H, Rayment, Jonathan H, Setiawan, Linda and Pilewski, Joseph M (2025). Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials. The Lancet Respiratory Medicine. doi: 10.1016/S2213-2600(25)00206-1 |
|
2024 Journal Article Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomesMadden, Danielle E., Baird, Timothy, Bell, Scott C., McCarthy, Kate L., Price, Erin P. and Sarovich, Derek S. (2024). Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes. Genome Medicine, 16 (1) 78, 78. doi: 10.1186/s13073-024-01346-z |
|
2024 Journal Article Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosisSaiman, Lisa, Waters, Valerie, Lipuma, John J., Hoffman, Lucas R., Alby, Kevin, Zhang, Sean X., Yau, Yvonne C., Downey, Damian G., Sermet-Gaudelus, Isabelle, Bouchara, Jean-Philippe, Kidd, Timothy J., Bell, Scott C. and Brown, A. Whitney (2024). Practical guidance for clinical microbiology laboratories: updated guidance for processing respiratory tract samples from people with cystic fibrosis. Clinical Microbiology Reviews, 37 (3), e0021521. doi: 10.1128/cmr.00215-21 |
|
2024 Conference Publication Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national studyDuplancic, Christine, Wainwright, Claire, Thomson, Rachel, Rogers, Geraint, Clements, Archie, Floto, Andre and Bell, Scott (2024). Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trialRice, Megan, Hicks, Daniel, Jong, Tiffany, Gailer, Nicolas, Joshi, Sri, Stevens, Luke, Lee, Kate, Thomson, Rachel, Burke, Andrew, Grimwood, Keith, Bell, Scott, Clark, Julia and Wainwright, Claire E. (2024). Developing a pharmacovigilance framework for an investigator led, non-commercial international adaptive platform trial. 15th Australasian Cystic Fibrosis Conference, Brisbane, QLD, Australia, 2–4 August 2024. Richmond, VIC, Australia: John Wiley & Sons. |
|
2024 Conference Publication Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT)Hicks, D., Jong, T., Rice, M., Gailer, N., Joshi, S., Stevens, L., Lee, K., Thomson, R., Burke, A., Grimwood, K., Bell, S., Clark, J. and Wainwright, C.E. (2024). Developing a pharmacovigilance framework for an investigator-led, non-commercial platform trial – finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT). 47th European Cystic Fibrosis Conference, Glasgow, United Kingdom, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s1569-1993(24)00244-3 |
